|
|
|
|
| LEADER |
01832nam a22004577i 4500 |
| 001 |
MUB01006528237 |
| 003 |
CZ BrMU |
| 005 |
20240105081058.0 |
| 008 |
231017t20232023xxu||||| |||||||||||eng d |
| STA |
|
|
|a POSLANO DO SKCR
|b 2024-01-15
|
| 020 |
|
|
|a 978-0-12-824304-6
|q (print)
|
| 040 |
|
|
|a BOD002
|b cze
|e rda
|
| 072 |
|
7 |
|a 615
|x Farmacie. Farmakologie
|2 Konspekt
|9 14
|
| 080 |
|
|
|a 615.012:001.891
|2 MRF
|
| 080 |
|
|
|a (075.8)
|2 MRF
|
| 100 |
1 |
|
|a Miller, Susan
|4 aut
|
| 245 |
1 |
0 |
|a Managing the drug discovery process :
|b insights and advice for students, educators, and practitioners /
|c Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart, David Spellmeyer
|
| 250 |
|
|
|a Second edition
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Elsevier,
|c [2023]
|
| 264 |
|
4 |
|c ©2023
|
| 300 |
|
|
|a xlii, 639 stran :
|b ilustrace
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a bez média
|b n
|2 rdamedia
|
| 338 |
|
|
|a svazek
|b nc
|2 rdacarrier
|
| 650 |
0 |
7 |
|a vývoj léčiv
|7 ph761292
|2 czenas
|
| 650 |
0 |
9 |
|a drug development
|2 eczenas
|
| 655 |
|
7 |
|a učebnice vysokých škol
|7 fd133772
|2 czenas
|
| 655 |
|
9 |
|a textbooks (higher)
|2 eczenas
|
| 700 |
1 |
|
|a Moos, Walter
|4 aut
|
| 700 |
1 |
|
|a Munk, Barbara H.
|7 ntk20221163240
|4 aut
|
| 700 |
1 |
|
|a Munk, Stephen
|4 aut
|
| 700 |
1 |
|
|a Hart, Charles
|4 aut
|
| 700 |
1 |
|
|a Spellmeyer, David
|4 aut
|
| CAT |
|
|
|a VARTECKA
|b 02
|c 20231017
|l MUB01
|h 0707
|
| CAT |
|
|
|a VARTECKA
|b 02
|c 20231218
|l MUB01
|h 1246
|
| CAT |
|
|
|a VARTECKA
|b 02
|c 20240105
|l MUB01
|h 0810
|
| CAT |
|
|
|c 20240115
|l MUB01
|h 1144
|
| LOW |
|
|
|a POSLANO DO SKCR
|b 2024-01-15
|
| 994 |
- |
1 |
|l MUB01
|l MUB01
|m BOOK
|1 KUK
|a Knihovna univ. kampusu
|2 VV
|b KUK - volný výběr
|3 611.5-MILL
|5 3147089913
|4 SIGNAL NEW
|8 20231017
|f 70
|f Prezenční
|g 2023-866
|r 20231218
|s kup
|
| AVA |
|
|
|a MED50
|b KUK
|c KUK - volný výběr
|d 611.5-MILL
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j VV
|